0001415889-24-016108.txt : 20240607
0001415889-24-016108.hdr.sgml : 20240607
20240607214516
ACCESSION NUMBER: 0001415889-24-016108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240529
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas John
CENTRAL INDEX KEY: 0001939103
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41599
FILM NUMBER: 241031360
MAIL ADDRESS:
STREET 1: C/O GENELUX CORPORATION
STREET 2: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENELUX Corp
CENTRAL INDEX KEY: 0001231457
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-267-9889
MAIL ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: GENELUX CORP
DATE OF NAME CHANGE: 20030508
4
1
form4-06072024_090608.xml
X0508
4
2024-05-29
0001231457
GENELUX Corp
GNLX
0001939103
Thomas John
C/O GENELUX CORPORATION
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE
CA
91361
true
false
false
false
0
Common Stock
2024-05-29
4
P
0
2500
A
465960
D
Common Stock Warrant (Right to Buy)
5.25
2024-05-29
4
P
0
2500
A
2024-05-29
2029-05-29
Common Stock
2500
2500
D
The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs.
The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.
/s/ Thomas Zindrick, J.D., Attorney-in-Fact
2024-06-07